Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

118.39 -2.33 (-1.93%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
65 66 Next >
Equity Index Futures Slightly Higher As U.S. Dollar Retreats
(Monday Market Open) Equity index futures pointed to a higher open as the U.S. dollar retreated from Friday’s rally. 
Via Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
NVIDIA, Tyson Foods, BioNTech And Some Other Big Stocks Moving Lower On Monday
  AMTD Digital Inc. (NYSE: HKD) dipped 21.8% to $563.71 on possible profit taking after the stock surged over the last few trading days. 
Via Benzinga
Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data
Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia. 
Via InvestorPlace
Why Is BioNTech (BNTX) Stock Down 7% Today?
BioNTech (BNTX) stock is on falling on Monday after the company released poor earnings results for its second quarter of 2022. 
Via InvestorPlace
BioNTech Dives As Second-Quarter Sales, Profit Broadly Miss Forecasts
The company's retained guidance was also weak at the midpoint. 
Via Investor's Business Daily
Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8
CNBC Celsius Withdraws Motion To Rehire CFO 
Via Benzinga
Recap: BioNTech Q2 Earnings
  BioNTech (NASDAQ:BNTX) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
Via Benzinga
Tesla, Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
BioNTech Earnings Shocker: Posts Lower Than Expected Q2 Profits, Revenues Fall
Via Benzinga
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares rose 46% to $6.98 in pre-market trading after jumping around 46% on Friday. The company recently said it expects unaudited... 
Via Benzinga
Analyst Ratings for BioNTech
Analysts have provided the following ratings for BioNTech (NASDAQ:BNTX) within the last quarter: 
Via Benzinga
U.S. Stock Futures Higher After Friday's Jobs Report
Pre-open movers 
Via Benzinga
Tyson Foods, Take-Two Interactive And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly higher this morning on Monday following the release of upbeat of jobs report on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Disney Leads Media Earnings This Week As Reporting Season Moves Past The Peak
We are past the peak of earnings season, and about 87% of the S&P 500 companies have already released their quarterly numbers, FactSet reports. 
Via Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years. 
Via Benzinga
Here's Why BioNTech Stock Is Moving
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results. 
Via Benzinga
Equity Index Futures Rebound Despite Concerns Over OPEC And China
(Wednesday Market Open) Stocks look to rebound as equity index futures point to a higher open and the dollar retreats from yesterday’s rally. But Fed speak and news out of OPEC and China present... 
Via Benzinga
BioNTech Earnings Conference Call Is Coming Up, Here's What You Need To Know
BioNTech (NASDAQ:BNTX) will host a conference call at 08:00 AM ET on August 8, 2022, to discuss Q2 2022 earnings results. How to Attend BioNTech (BNTX) Conference Call Follow this link to access the... 
Via Benzinga
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now
(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open.... 
Via Benzinga
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... 
Via Benzinga
5 Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
Is The Energy Ready To Rebound?
(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs. 
Via Benzinga
Pfizer Ticks Higher As Covid Vaccine, Pill Carry Its Second-Quarter Beat
The company projects strong sales of Comirnaty and Paxlovid in 2022. 
Via Investor's Business Daily
Is Moderna's Cheaper Valuation A Buying Signal?
Moderna is one of the least expensive companies in the S&P 500 in terms of valuation. In this article, we'll examine other aspects of the company. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Pfizer/BioNTech Start Ohase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant
Via Benzinga
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
From BioNTech SE
Via GlobeNewswire
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
65 66 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.